ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1038

Tumor Necrosis Factor Alpha and Peptidylarginine Deiminase 4 in Lung and Joint Inflammation

Mandar Bawadekar1, Annette Gendron-Fitzpatrick2, Thomas F. Warner3, Lennart K.A. Lundblad4, Paul Thompson5 and Miriam A. Shelef1,6, 1Medicine, University of Wisconsin, Madison, WI, 2Comparative Pathology Laboratory of the Research Animal Resources Center and Pathobiological Sciences, University of Wisconsin, Madison, WI, 3Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, 4Medicine, The University of Vermont, Burlington, VT, 5University of Massachusetts, Worcester, MA, 6Medicine, William S. Middleton Memorial Veterans Hospital, Madison, WI

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: animal models and tumor necrosis factor (TNF), citrullination, Lung Disease, PAD, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Rheumatoid Arthritis - Animal Models I

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: The relationship between lung and joint inflammation in rheumatoid arthritis is poorly understood. About 10% of people with rheumatoid arthritis develop interstitial lung disease and people who have early rheumatoid arthritis or anti-citrullinated protein antibodies (ACPAs) without clinical arthritis have increased rates of subclinical lung disease. Also, citrullinated proteins can be found in diseased lungs similar to inflamed joints. Taken together, these observations suggest that one or both of two possible lung/joint relationships may exist. Lung inflammation may be an inciting event in rheumatoid arthritis development possibly by triggering ACPA formation and/or lung inflammation and arthritis may be two manifestations of a similar underlying pathology. However the true mechanism is unknown. Overexpression of TNFα in mice causes both an inflammatory destructive arthritis similar to rheumatoid arthritis as well as severe lung inflammation. We have previously shown that the citrullinating enzyme peptidylarginine deiminase 4 (PAD4) contributes to arthritis in these mice, but its role in lung disease is unknown. Here, we employ mice that overexpress TNFα to address several basic questions about the relationship between TNFα, citrullination, PAD4, arthritis, and lung inflammation.

Methods: Ankle joint and lung tissue from mice that systemically overexpress TNFα (TNF+) and wild type littermates as well as TNF+PAD4+/+ and TNF+PAD4-/- littermates were flash frozen and homogenized. Protein lysates were diluted in trichloroacetic acid, incubated with Rh-PG (a citrulline detection probe), quenched, washed, subjected to gel electrophoresis, imaged, stained with Coomassie, and re-imaged to determine the extent of total protein citrullination. Lungs from TNF+PAD4+/+ and TNF+PAD4-/- littermates were fixed, sectioned, stained with hematoxylin and eosin (H&E), and scored in a blinded manner for the severity of several characteristics of lung inflammation. Ankle joints from 22 month old mice that overexpress TNFα only in the lung under the control of the surfactant promoter and littermate controls were fixed, sectioned, stained with H&E, and scored for arthritis severity.

Results: TNF+ mice have increased gross protein citrullination in their joints and lungs at 5 months of age, but not 2 or 3.5 months of age compared to wild type. There was no difference between TNF+PAD4+/+ and TNF+PAD4-/- mice in gross protein citrullination in either joints or lungs at 5 months of age, however TNF+PAD4-/- mice had reduced lung disease severity compared to TNF+PAD4+/+ mice. No arthritis was detected in the mice that overexpress TNFα only in the lungs.

Conclusion: PAD4 contributes to both lung and joint inflammation downstream of TNFα, without having a required role in generalized protein citrullination in these tissues. Further, TNFα induced lung inflammation does not drive arthritis in mice.


Disclosure: M. Bawadekar, None; A. Gendron-Fitzpatrick, None; T. F. Warner, None; L. K. A. Lundblad, None; P. Thompson, Padlock Therapeutics, 9; M. A. Shelef, None.

To cite this abstract in AMA style:

Bawadekar M, Gendron-Fitzpatrick A, Warner TF, Lundblad LKA, Thompson P, Shelef MA. Tumor Necrosis Factor Alpha and Peptidylarginine Deiminase 4 in Lung and Joint Inflammation [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/tumor-necrosis-factor-alpha-and-peptidylarginine-deiminase-4-in-lung-and-joint-inflammation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tumor-necrosis-factor-alpha-and-peptidylarginine-deiminase-4-in-lung-and-joint-inflammation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology